[Remote] Manager, Patient Advocacy & Engagement at Orca Bio

Remote

Orca Bio Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Patient AdvocacyStakeholder EngagementRelationship BuildingCommunity OutreachGrant ManagementClinical Trial SupportMedical EducationExternal EngagementBlood Cancer CommunityBiotechnology

Questions & Answers

Common questions about this position

Is this position remote or does it require office work?

The position is preferred to be remote in Chicago or the mid-west US.

What are the key skills required for the Manager, Patient Advocacy & Engagement role?

Key skills include a patient-centric mindset, ability to build trusted partnerships with stakeholders, developing advocacy initiatives, strong written and verbal communication for translating complex science, and knowledge of oncology/hematology advocacy ecosystems.

What is the salary or compensation for this role?

This information is not specified in the job description.

What is the company culture like at Orca Bio?

Orca Bio is a patient-driven organization with a patient-first culture, focused on transforming lives through high-precision cell therapy and elevating patient stories, perspectives, and unmet needs across the company.

What makes a strong candidate for this position?

A strong candidate embodies a patient-centric mindset, has experience building trusted partnerships in the blood cancer advocacy community, and possesses strong communication skills to translate complex science into accessible language while understanding oncology/hematology ecosystems.

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI